Multigram-scale synthesis of GSK 2,256,294, an inhibitor of soluble epoxide hydrolase in clinical evaluation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bellien J, Joannides R, Richard V (2011) Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases Thuillez C. Pharmacol Ther 131:1–17. https://doi.org/10.1016/j.pharmthera.2011.03.015
Cesar J, Nadrah K, Dolenc MS (2004) Solid-phase synthesis of amidines by the reduction of amidoximes. Tetrahedron Lett 45:7445–7449. https://doi.org/10.1016/j.tetlet.2004.08.055
Chen XJ, Chen XQ, Huang XJ, Qin C, Fang YK, Liu Y, Zhang GB, Pan DJ, Wang W, Xie MJ (2016) Soluble epoxide hydrolase inhibition provides multi-target therapeutic effects in rats after spinal cord injury. Mol Neurobiol 53:1565–1578. https://doi.org/10.1007/s12035-015-9118-1
Ding Y, Thalji PK, Marino JPJR (2009) Novel sEH inhibitors and their use. WO Patent 2009049157:A1
John CS, William AB (1950) An improved procedure for the condensation of potassium phthalimide with organic halides. J Am Chem Soc 72:2786–2788. https://doi.org/10.1021/ja01162a527
Joshi VM, Sojitra C, Sasane S, Shukla M, Chauhan R, Chaubey V, Jain S, Shah K, Mande H, Soman S, Pamidimukkala PS, Shah SR, Pandey B, Singh KK, Agarwal S (2020) Practical and efficient synthesis of 2-thio-imidazole derivative-ZY12201: a potent TGR5 agonist. Org Process Res Dev 24:1508–1514. https://doi.org/10.1021/acs.oprd.0c00234
Kühl N, Graf D, Bock J, Behnam MAM, Leuthold M, Klein CD (2020) A new class of dengue and west nile virus protease inhibitors with submicromolar activity in reporter gene denv-2 protease and viral replication assays. J Med Chem 63:8179–8197. https://doi.org/10.1021/acs.jmedchem.0c00413
Lazaar AL, Yang L, Boardley RL, Goyal NS, Robertson J, BaLdwin S, Newby DE, Wilkinson LB, Tal-Singer R, Mayer RJ, Cheriyan J (2015) Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor. Br J Clin Pharmaco 81:971–979. https://doi.org/10.1111/bcp.12855
Luther JM, Brown NJ (2016) Epoxyeicosatrienoic acids and glucose homeostasis in mice and men. Prostag Other Lipid M 125:2–7. https://doi.org/10.1016/j.prostaglandins.2016.07.010
Muley L, Baum B, Smolinski M, Freindorf M, Heine A, Klebe G, Hangauer DG (2010) Enhancement of hydrophobic interactions and hydrogen bond strength by coperativity: synthesis, modeling, and molecular dynamics simulationsof a congeneric series of thrombin inhibitors. J Med Chem 53:2126–2135. https://doi.org/10.1021/jm9016416
Newman JW, Morisseau C, Hammock BD (2005) Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog Lipid Res 44:1–51. https://doi.org/10.1016/j.plipres.2004.10.001
Shebl RE, Abderaboh MM (2015) Bi-level positive airway pressure ventilation for patients with stable hypercapnic chronic obstructive pulmonary disease. Egypt J Chest Dis Tuberc 64:395–398. https://doi.org/10.1016/j.ejcdt.2015.02.004
Shen HC, Hammock BD (2012) Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications. J Med Chem 55:1789–1808. https://doi.org/10.1021/jm201468j10.1021/jm201468j